Please provide your email address to receive an email when new articles are posted on . HPV testing rates in oropharyngeal cancer have increased over time but remain suboptimal. Testing uptake varies ...
Intensity-modulated radiation therapy did not increase the risk for feeding tube dependence for patients with oropharyngeal ...
Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives.
A novel multifeature human papillomavirus (HPV) whole genome sequencing liquid biopsy assay detected circulating tumor HPV DNA (ctHPV DNA) with 79% sensitivity and 100% specificity up to 7.8 years ...
AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination. HealthDay News — Version 9 of the American Joint Committee on Cancer (AJCC) ...
Proton therapy did not outperform IMRT in quality-of-life outcomes for patients with oropharyngeal cancer. Both treatments achieved similarly strong control and survival, according to new trial ...
A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback